A Preclinical Candidate Targeting Mycobacterium tuberculosis KasA

Published Mycobacterium tuberculosis β-ketoacyl-ACP synthase KasA inhibitors lack sufficient potency and/or pharmacokinetic properties. A structure-based approach was used to optimize existing KasA inhibitor DG167. This afforded indazole JSF-3285 with a 30-fold increase in mouse plasma exposure. Bio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Chem Biol
Main Authors: Inoyama, Daigo, Awasthi, Divya, Capodagli, Glenn C., Tsotetsi, Kholiswa, Sukheja, Paridhi, Zimmerman, Matthew, Li, Shao-Gang, Jadhav, Ravindra, Russo, Riccardo, Wang, Xin, Grady, Courtney, Richmann, Todd, Shrestha, Riju, Li, Liping, Ahn, Yong-Mo, Liang, Hsin Pin Ho, Mina, Marizel, Park, Steven, Perlin, David S., Connell, Nancy, Dartois, Véronique, Alland, David, Neiditch, Matthew B., Kumar, Pradeep, Freundlich, Joel S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7245553/
https://ncbi.nlm.nih.gov/pubmed/32197094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chembiol.2020.02.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados